Saltar al contenido principal
Elsevier

Lung Cancer, An Issue of Hematology/Oncology Clinics

  • 1 Edición, Volumen 31-1 - 3 de diciembre de 2016
  • Última edición
  • Autores: Roy S. Herbst, Daniel Morgensztern
  • Idioma: Inglés

This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally… Leer más

Descripción

This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many more!

Detalles del producto

  • Edición: 1
  • Última edición
  • Volumen: 31-1
  • Publicado: 3 de diciembre de 2016
  • Idioma: Inglés

Sobre los autores

RH

Roy S. Herbst

Afiliaciones y experiencia
Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine, USA

DM

Daniel Morgensztern

Afiliaciones y experiencia
Washington University School of Medicine